Objective: To determine minimum clinically meaningful improvements in peak
expiratory flow rate (PEFR) and dyspnea visual analog score (VAS) in patien
ts with acute asthma exacerbation. Methods: Patients presenting to the emer
gency department (ED) with acute asthma exacerbation were eligible. The PEF
R and VAS were assessed at presentation and after initial asthma therapy. D
uring reassessment, subjects were asked to describe their asthma symptoms a
s "much better," "a little better." "no change," "a little worse," or "much
worse." Correspondence between self-reported improvement and changes in PE
FR and VAS was assessed. The "minimum clinically significant change" in eit
her index was defined as the difference between pre- and posttreatment meas
ures in subjects reporting their symptoms "a little better." Results: One h
undred fifty-six subjects were included. Asthma symptoms were "much better"
in 99 (64%), "a little better" in 41 (26%), and "unimproved" (composed of
patients describing symptoms as "no change," "a little worse," or "much wor
se") in 16 (10%). The mean VAS change among the "a little better" subjects
was 2.2 cm (95% CI = 1.1 to 3.4), significantly greater than the -0.4 cm (9
5% CI = -2.1 to 1.4) change in the "unimproved" subjects. The mean change i
n percent predicted PEFR among the "a little better" subjects was 11.9 (95%
CI = 7.3 to 16.1), not statistically different from the change of 6.1 (95%
CI = 1.1 to 11.3) in the "no change" subjects. The "much better" group sho
wed significantly greater changes in both measures than either of the other
groups. A VAS change of greater than or equal to 0.5 cm reliably discrimin
ated between subjects with and without symptom improvement. Conclusions: Im
provements in VAS of 2.2 cm and in predicted PEFR of about 12 percentage po
ints are minimal clinically significant improvements during ED asthma thera
py. The dyspnea VAS is valid in assessing symptomatic changes and may detec
t small subjective improvements better than the PEFR.